Castleark Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,340
| Closed | -$417K | – | 327 |
|
|
2024
Q3 | $417K | Sell |
3,340
-400
| -11% | -$50K | 0.02% | 220 |
|
|
2024
Q2 | $591K | Buy |
3,740
+1,390
| +59% | +$220K | 0.02% | 221 |
|
|
2024
Q1 | $304K | Buy |
+2,350
| New | +$304K | 0.01% | 241 |
|
|
2023
Q1 | – | Sell |
-41,440
| Closed | -$5.37M | – | 320 |
|
|
2022
Q4 | $5.37M | Sell |
41,440
-9,530
| -19% | -$1.23M | 0.28% | 90 |
|
|
2022
Q3 | $5.63M | Buy |
+50,970
| New | +$5.63M | 0.31% | 72 |
|
|
2021
Q1 | – | Sell |
-7,945
| Closed | -$1.36M | – | 372 |
|
|
2020
Q4 | $1.36M | Sell |
7,945
-815
| -9% | -$139K | 0.05% | 217 |
|
|
2020
Q3 | $1.23M | Buy |
8,760
+3,050
| +53% | +$428K | 0.05% | 208 |
|
|
2020
Q2 | $916K | Buy |
+5,710
| New | +$916K | 0.04% | 214 |
|
|
2019
Q2 | – | Sell |
-11,210
| Closed | -$1.34M | – | 393 |
|
|
2019
Q1 | $1.34M | Sell |
11,210
-220
| -2% | -$26.2K | 0.05% | 247 |
|
|
2018
Q4 | $1.25M | Sell |
11,430
-69,875
| -86% | -$7.62M | 0.05% | 253 |
|
|
2018
Q3 | $13.1M | Buy |
81,305
+11,835
| +17% | +$1.91M | 0.38% | 90 |
|
|
2018
Q2 | $9.18M | Sell |
69,470
-33,708
| -33% | -$4.46M | 0.28% | 117 |
|
|
2018
Q1 | $7.64M | Sell |
103,178
-179,632
| -64% | -$13.3M | 0.24% | 132 |
|
|
2017
Q4 | $15.7M | Sell |
282,810
-1,220
| -0.4% | -$67.9K | 0.47% | 62 |
|
|
2017
Q3 | $12.9M | Buy |
+284,030
| New | +$12.9M | 0.4% | 79 |
|